APA (7 वां संस्करण) प्रशस्ति पत्र

Shawn, I. H., & Jamiruddin, M. R. (2024). Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: A systematic review and meta-analysis. Brac University.

शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र

Shawn, Ibna Hasan, और Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.

एमएलए (8वां संस्करण) प्रशस्ति पत्र

Shawn, Ibna Hasan, और Mohd. Raeed Jamiruddin. Assessing Therapeutic Safety and Efficacy of Pazopanib, Pembrolizumab Plus Axitinib and Nivolumab Plus Ipilimumab in Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Brac University, 2024.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.